Us Bancorp \De\ Intercept Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$9.99 - $18.71 $4,465 - $8,363	447 Added 532.14%	531 $9,000
Q2 2023 Aug 09, 2023	SELL	$9.17 - $19.29 $3,658 - $7,696	-399 Reduced 82.61%	84 $0
Q1 2023 May 09, 2023	BUY	$12.53 - $21.71 $6,051 - $10,485	483 New	483 $6,000
Q3 2022 Oct 27, 2022	BUY	$12.21 - $19.7 $12,075 - $19,483	989 New	989 $14,000
Q2 2022 Aug 01, 2022	SELL	$11.23 - $19.59 $1,426 - $2,487	-127 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$13.37 - $17.79 $949 - $1,263	71 Added 126.79%	127 $2,000
Q4 2021 Feb 11, 2022	BUY	$14.28 - $19.53 $799 - $1,093	56 New	56 $1,000
Q2 2021 Aug 05, 2021	SELL	$15.46 - $24.5 $3,061 - $4,851	-198 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$19.33 - $37.75 $309 - $604	-16 Reduced 7.48%	198 $5,000
Q4 2020 Feb 04, 2021	BUY	$24.48 - $42.47 $4,700 - $8,154	192 Added 872.73%	214 $5,000
Q3 2020 Nov 10, 2020	SELL	$39.09 - $53.44 $2,579 - $3,527	-66 Reduced 75.0%	22 $1,000
Q2 2020 Aug 07, 2020	BUY	$46.7 - $92.04 $4,109 - $8,099	88 New	88 $4,000
Q1 2020 May 13, 2020	SELL	$48.35 - $118.68 $1,402 - $3,441	-29 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$91.83 - $120.68 $107,624 - $141,436	-1,172 Reduced 97.59%	29 $3,000
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $3,860 - $5,690	45 Added 3.89%	1,201 $121,000
Q3 2018 Nov 01, 2018	SELL	$88.49 - $127.55 $54,775 - $78,953	-619 Reduced 34.87%	1,156 $146,000
Q2 2018 Aug 08, 2018	BUY	$60.0 - $85.67 $1,440 - $2,056	24 Added 1.37%	1,775 $149,000
Q1 2018 May 08, 2018	BUY	$52.72 - $67.25 $82,295 - $104,977	1,561 Added 821.58%	1,751 $108,000
Q4 2017 Feb 02, 2018	BUY	$58.2 - $72.76 $6,751 - $8,440	116 Added 156.76%	190 $11,000
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $4,218 - $8,787	74	74 $4,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account